The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-4159
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Does Neutron Radiation Therapy Potentiate an Immune Response to Merkel Cell Carcinoma?

International Journal of Particle Therapy
Nuclear MedicineRadiologyMolecular Physics,ImagingOpticsAtomic
2018English

The Alveolar Immune Cell Landscape Is Dysregulated in Checkpoint Inhibitor Pneumonitis

Journal of Clinical Investigation
Medicine
2019English

Combination VEGFR/immune Checkpoint Inhibitor Therapy: A Promising New Treatment for Renal Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2018English

Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibitor Therapy

Case Reports in Oncological Medicine
Oncology
2017English

Immune Checkpoint Therapy and the Search for Predictive Biomarkers

Cancer Journal
Cancer ResearchOncology
2016English

Current Landscape and Future Directions of Biomarkers for Predicting Responses to Immune Checkpoint Inhibitors

Cancer Management and Research
Oncology
2018English

Identification of Responders to Immune Checkpoint Therapy: Which Biomarkers Have the Highest Value?

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2019English

114 the Genomic Landscape of Sebaceous Cell Carcinoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

T-Cell Lymphoma Secondary to Checkpoint Inhibitor Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy